Product Images Xermelo
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Xermelo NDC 70720-125 by Tersera Therapeutics Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - xer00 0002 01
Figure 1 - xer00 0002 02
Principal Display Panel - 3x7 weekly pack - xer00 0002 03
XERMELO tablets contain 250 mg of telotristat ethyl and come in a weekly pack with 21 tablets. The active ingredient is produced in China and the tablets are manufactured in the USA by TerSera Therapeutics LLC. They are only for oral use and should be stored at room temperature. Dosage and administration information is available in the package insert. This medication should be kept out of reach of children. The NDC number for this medication is 70720-125-22.*
Principal Display Panel - 28 Day Case Label - xer00 0002 04
XERMELO is a medication available in tablet form and containing telotristat ethyl. The medication is indicated for the treatment of Carcinoid Syndrome Diarrhea (CSD) in combination with SSA (somatostatin analog) therapy in adults inadequately controlled by SSA therapy alone.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.